Advertisement
Subscribe now
Log in
November 20, 2026 13:19
E-Paper
E-Magazine
Corporate
CEO Talk
Biz Link
PR Newswire
Media OutReach Newswire
Investing
M&A
Outbound Investment
Investing in Haiphong
Investing in Ho Chi Minh City
Your Consultant
KPMG
PwC
Indochine Counsel
Vilasia
Ansarada
Green Growth
Energy Efficiency
Rethinking Plastics
BASF
Property
Green Buildings
Industrial Properties
Money
Insurance
Smart Payment Trends
Stock Monitor
Infographics
Timeout
Travel
Hotels & Restaurants
The Insider
Entertainment
Lifestyle
Sports
Photos
Society
Swing for the Kids
CSR
World News
Tags
Phase 1 Plodicitinib clinical data
Daewoong Pharmaceutical presents Phase 1 Plodicitinib clinical data at ACR
November 20, 2026 | 12:56
South Korean drugmaker Daewoong Pharmaceutical presented Phase 1 clinical trial data for its autoimmune disease candidate Plodicitinib during the ACR Convergence 2026 conference on 17 November 2026.
Latest News
HKMA annual conference attracts nearly 2,000 participants in Hong Kong
Thyroscope and TORC partner on thyroid eye disease research
Daewoong Pharmaceutical presents Phase 1 Plodicitinib clinical data at ACR
Hong Kong Jockey Club supports Asia Pacific Youth Challenge
Mobile Version